INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$4.31M
78.4K sh
Oct 15, 2026
Page 155 of 1649
← PrevNext →
Oct 19, 2026
traded Oct 15, 2026
+4d
SEC Form 4

Evidence

10
KP
Kirol Charles PeterChief Operating Officer
PTONPELOTON INTERACTIVE, INC.
Option exercise
M—
56.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

10
CM
Canning Susan M.SVP, CLO, Corporate Secretary
HAYWHayward Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$749K
3,302 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
57.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CP
Carlson Michael PaulGENERAL COUNSEL & SECRETARY
NONENONESterling Real Estate Trust
Grant or award
A$172
7 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
122.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
MP
McClaskey James PaulChief Accounting Officer
INSGINSEEGO CORP.
Tax withholding
F$1,930
465 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
DA
Dianaty AliEVP Ch. Prod. & Tech Officer
MMEDMiniMed Group, Inc.
Grant or award
A—
11.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CB
Campbell BrandiEXECUTIVE VICE PRESIDENT
BMRCBank of Marin Bancorp
Disposition to issuer
D—
18.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Option exercise
M—
110.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GM
Gilday Michael M.Director
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
328 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
PM
Polovitz MarkTRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$923
38 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$338K
1,487 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
WA
Woronoff Michael ADirector
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Grant or award
A—
500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.14M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
BS
Blouin Ann ScottDirector
ENSGENSIGN GROUP, INC
Grant or award
A—
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
410.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
TS
Thomsen Joel S.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$1,594
66 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
27.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$658K
47.6K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,025 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CB
Crowley Kyle BradfordDirector
PUMPProPetro Holding Corp.
Grant or award
A—
11.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Tax withholding
F$36K
487 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
61.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
2.00M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
JP
Johnson Christine ProcopioSVP, CSO
KWRQUAKER CHEMICAL CORP
Grant or award
A—
504 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Tax withholding
F$46K
17.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SP
Siegrist Jonathan PhilipEVP of R&D & CTO
QDELQuidelOrtho Corp
Option exercise
M—
18.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SE
Schreiner Megan E.PRESIDENT
NONENONESterling Real Estate Trust
Grant or award
A$84.69
3 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GM
Gordon Susan M.Director
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
328 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VT
Vines TimothyDirector
RFREGIONS FINANCIAL CORP
Grant or award
A$31K
1,144 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K